Abstract
Objective
Cleft lip scars can significantly impact patients’ facial esthetics and psychological well-being. This meta-analysis aimed to evaluate the effectiveness of various non-surgical interventions in reducing cleft lip scars.
Methods
A systematic search was performed across PubMed, Embase, Scopus, Cochrane, and Web of Science databases up to May 21, 2024. Inclusion criteria encompassed human studies with cohort or randomized controlled trial (RCT) designs that assessed non-surgical interventions for reducing cleft lip scarring following surgery. Articles in any language, regardless of publication date, were considered. Eligible studies underwent quality assessment, and data were extracted for an inverse variance random-effects meta-analysis.
Results
Of 1664 initially identified articles, 14 met the inclusion criteria for review, with 8 included in the meta-analysis. The reviewed studies primarily focused on botulinum toxin type A (BTA) and laser treatments as non-surgical approaches. Meta-analysis revealed significant improvement in scar appearance with laser therapy (P < .001) but not with BTA (P = .15) when the assessment was conducted by the Vancouver scar scale (VSS). BTA also had no significant effect on scar width reduction (P > .05), but improved scar appearance based on the subjective visual analogue scale (VAS) assessment (P < .001).
Conclusions
Based on the VSS index, laser therapy improved scar appearance more effectively than BTA. However, BTA enhanced esthetics as measured subjectively by VAS. These findings support non-surgical interventions as a viable approach for managing cleft lip scars.
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
